NCT05064566 is a clinical trial of caries assessment in Caries, sponsored by Nazan Kocak Topbas.

Who is sponsoring NCT05064566?

NCT05064566 is sponsored by Nazan Kocak Topbas.

What drugs are being tested in NCT05064566?

Interventions in NCT05064566: caries assessment.

What condition does NCT05064566 study?

NCT05064566 studies Caries, Diagnoses Disease.

Is NCT05064566 still recruiting?

NCT05064566 is currently status unknown. Last updated 1 October 2021.

Last reviewed 2021-10-01 · How we verify

NCT05064566

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Caries Detection Methods

Status unknown Last updated 1 October 2021

What this trial tests

trial testing caries assessment in Caries in 101 participants. Status unknown.

Timeline

20 October 2021

Primary endpoint
20 October 2022

20 December 2022

Quick facts

Lead sponsor	Nazan Kocak Topbas
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	101
Start date	20 October 2021
Primary completion	20 October 2022
Estimated completion	20 December 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

caries assessment

Conditions studied

Caries — all drugs for Caries →
Diagnoses Disease — all drugs for Diagnoses Disease →

Sponsor

Nazan Kocak Topbas

Who can join

18 and older, any sex, with Caries or Diagnoses Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim will be to compare the diagnostic performance of clinical visual examination (ICDAS II), intraoral/bite wing radiography (BW), near infrared light transillumination (NIR-LT), and laser fluorescence (LF), in comparison to microcomputed tomography (micro-CT) for the detection of non-cavitated occlusal enamel and dentin caries in third molar teeth. Potential participants will be consecutively recruited.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Performance of Diagnostic Methods in Third Molar Teeth with Early Occlusal Caries.
Kocak-Topbas N, Kamburoğlu K, Ertürk-Avunduk AT, Ozemre MO, et al · · 2023 · cited 3× · PMID 36673093 · DOI 10.3390/diagnostics13020284

Verify or expand the search:

Other trials of caries assessment

Trials testing the same drug.

NCT05652231 — Assessment of Dental Caries Among a Group of Institutionalized Orphan Children Compared to Parented School Children · completed

Other recruiting trials for Caries

Currently open trials in the same condition.

NCT06677983 — Clinical Performance and Acceptance of Bioflx Crowns · NA · recruiting
NCT05748327 — Trial With Two New Tooth-colored Restorative Materials in Class I/II Cavities · NA · active not recruiting
NCT05505084 — Alveolar Ridge Preservation Following Tooth Extraction. · active not recruiting
NCT04796974 — Clinical Evaluation of "Cention Forte" Restorative Material · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05064566 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nazan Kocak Topbas
Last refreshed: 1 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05064566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing